Difference between generic and multiple sclerosis-specific quality of life instruments regarding the assessment of treatment efficacy von Özakbas, S, Akdede, B.B, Kösehasanogullari, G, Aksan, Ö, Idiman, E

Volltext

Feasibility of exergaming for upper extremity rehabilitation in people with multiple sclerosis: prospective clinical trial von Ozdogar, A. T., Emec, M., Kaya, E., Karakas, H., Dastan, S., Kahraman, T., Aslan, T., Baba, C., Ozcanhan, M. H., Ozakbas, S.

Volltext

Cognition as a parameter in monitoring the effect of multiple sclerosis relapse treatment: A prospective controlled study von Piri Cinar, B., Baba, C., Demir, S., Uzunkopru, C., Seferoglu, M., Gungor Dogan, I., Cilingir, V., Acikgoz, M., Bulbul, N.G., Sivaci, A.O., Cekic, S., Yigit, P., Eroglu, S., Beckmann, Y., Ozakbas, S.

Volltext

Five-year real-world data on fingolimod treatment's effects on cognitive function von Ozakbas, S., Piri Cinar, B., Yigit, P., Baba, C., Sagici, O.

Volltext

Utilization of the brief international cognitive assessment for multiple sclerosis during treatment of relapses in patients with multiple sclerosis von Oztürk, O, Piri Cinar, B, Ozakbas, S

Volltext

Comparison of McDonald 2005, McDonald 2010 and Swanton criteria for prediction of conversion from clinically isolated syndrome to multiple sclerosis von Piri Cinar, B, Ozakbas, S

Volltext

The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals? von Sen, S., Karabudak, R., Schiavetti, I., Demir, S., Ozakbas, S., Tutuncu, M., Petek Balci, B., Turan, O.F., Uzunkopru, C., Koseoglu, M., Yetkin, M.F., Gunduz, T., Gumus, H., Kale Icen, N., Carmisciano, L., Terzi, M., Acar, P., Gungor Dogan, I., Baba, C., Tuncer, A., Uygunoglu, U., Sormani, M.P., Efendi, H., Siva, A.

Volltext

Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom von Spelman, T, Herring, W L, Acosta, C, Hyde, R, Jokubaitis, V G, Pucci, E, Lugaresi, A, Laureys, G, Havrdova, E K, Horakova, D, Izquierdo, G, Eichau, S, Ozakbas, S, Alroughani, R, Kalincik, T, Duquette, P, Girard, M, Petersen, T, Patti, F, Csepany, T, Granella, F, Grand'Maison, F, Ferraro, D, Karabudak, R, Jose Sa, M, Trojano, M, van Pesch, V, Van Wijmeersch, B, Cartechini, E, McCombe, P, Gerlach, O, Spitaleri, D, Rozsa, C, Hodgkinson, S, Bergamaschi, R, Gouider, R, Soysal, A, Castillo-Triviño, Prevost, J, Garber, J, de Gans, K, Ampapa, R, Simo, M, Sanchez-Menoyo, J L, Iuliano, G, Sas, A, van der Walt, A, John, N, Gray, O, Hughes, S, De Luca, G, Onofrj, M, Buzzard, K, Skibina, O, Terzi, M, Slee, M, Solaro, C, Oreja-Guevara, Ramo-Tello, C, Fragoso, Y, Shaygannejad, V, Moore, F, Rajda, C, Aguera Morales, E, Butzkueven, H

Volltext

Movement disorders in demyelinating diseases von Colakoglu, B. Dönmez, Idiman, E, Ozakbas, S

Volltext

Monthly pulse methylprednisolone as an add-on therapy is effective in long-term treatment of relapsing remitting multiple sclerosis von Ozakbas, S, Piri Cinar, B, Kahraman, T, Kosehasanogullari, G, Oz, D

Volltext

Nitric oxide as an activity marker in multiple sclerosis von ACAR, G, IDIMAN, F, IDIMAN, E, KIRKALI, G, CAKMAKCI, H, ÖZAKBAS, S

Volltext

Pattern of cognitive impairment and related factors in clinically isolated syndrome von Ozakbas, S, Piri Cinar, B, Gurkan, A, Ozturk, O, Idiman, E

Volltext

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis von Simpson-Yap, Steve, De Brouwer, Edward, Kalincik, Tomas, Rijke, Nick, Hillert, Jan A., Walton, Clare, Edan, Gilles, Moreau, Yves, Spelman, Tim, Geys, Lotte, Parciak, Tina, Gautrais, Clement, Lazovski, Nikola, Pirmani, Ashkan, Ardeshirdavanai, Amin, Forsberg, Lars, Glaser, Anna, McBurney, Robert, Schmidt, Hollie, Bergmann, Arnfin B., Braune, Stefan, Stahmann, Alexander, Middleton, Rodden, Salter, Amber, Fox, Robert J., van der Walt, Anneke, Butzkueven, Helmut, Alroughani, Raed, Ozakbas, Serkan, Rojas, Juan I., van der Mei, Ingrid, Nag, Nupur, Ivanov, Rumen, Sciascia do Olival, Guilherme, Dias, Alice Estavo, Magyari, Melinda, Brum, Doralina, Mendes, Maria Fernanda, Alonso, Ricardo N., Nicholas, Richard S., Bauer, Johana, Chertcoff, Aníbal Sebastián, Zabalza, Anna, Arrambide, Georgina, Fidao, Alexander, Comi, Giancarlo, Peeters, Liesbet

Volltext

Early clinical markers of aggressive multiple sclerosis von Malpas, Charles B, Manouchehrinia, Ali, Sharmin, Sifat, Roos, Izanne, Horakova, Dana, Havrdova, Eva Kubala, Trojano, Maria, Izquierdo, Guillermo, Eichau, Sara, Bergamaschi, Roberto, Sola, Patrizia, Ferraro, Diana, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grammond, Pierre, Grand'Maison, Francois, Ozakbas, Serkan, Van Pesch, Vincent, Granella, Franco, Hupperts, Raymond, Pucci, Eugenio, Boz, Cavit, Sidhom, Youssef, Gouider, Riadh, Spitaleri, Daniele, Soysal, Aysun, Petersen, Thor, Verheul, Freek, Karabudak, Rana, Turkoglu, Recai, Ramo-Tello, Cristina, Terzi, Murat, Cristiano, Edgardo, Slee, Mark, McCombe, Pamela, Macdonell, Richard, Fragoso, Yara, Olascoaga, Javier, Altintas, Ayse, Olsson, Tomas, Butzkueven, Helmut, Hillert, Jan, Kalincik, Tomas

Volltext

Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study von Spelman, Tim, Simoneau, Gabrielle, Hyde, Robert, Kuhelj, Robert, Alroughani, Raed, Ozakbas, Serkan, Karabudak, Rana, Yamout, Bassem I, Khoury, Samia J, Terzi, Murat, Boz, Cavit, Horakova, Dana, Kubala Havrdova, Eva, Weinstock-Guttman, Bianca, Patti, Francesco, Altintas, Ayse, Mrabet, Saloua, Gouider, Riadh, Inshasi, Jihad, Shaygannejad, Vahid, Eichau, Sara, Ward, W Luke, Butzkueven, Helmut

Volltext

Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registry von Kenney, Rachel, Liu, Mengling, Patil, Sachi, Alroughani, Raed, Ampapa, Radek, Bergamaschi, Roberto, Boz, Cavit, Butzkueven, Helmut, Gomez, Jose Cabrera, Cartechini, Elisabetta, Madueño, Sara Eichau, Ferraro, Diana, Grand-Maison, Francois, Granella, Franco, Horakova, Dana, Izquierdo Ayuso, Guillermo, Kalincik, Tomas, Lizrova Preiningerova, Jana, Lugaresi, Alessandra, Onofrj, Marco, Ozakbas, Serkan, Patti, Francesco, Sola, Patrizia, Soysal, Aysun, Spitaleri, Daniele Litterio A., Terzi, Murat, Turkoglu, Recai, van Pesch, Vincent, Saidha, Shiv, Thorpe, Lorna E., Galetta, Steven L., Balcer, Laura J., Kister, Ilya, Spelman, Tim

Volltext

Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis : results from MSBase registry von Spelman, T, Ozakbas, S, Alroughani, R, Terzi, M, Hodgkinson, S, Laureys, Guy, Kalincik, T, Van Der Walt, A, Yamout, B, Lechner-Scott, J, Soysal, A, Kuhle, J, Sanchez-Menoyo, JL, Blanco Morgado, Y, Spitaleri, D, van Pesch, V, Horakova, D, Ampapa, R, Patti, F, Macdonell, R, Al-Asmi, A, Gerlach, O, Oh, J, Altintas, A, Tundia, N, Wong, SL, Butzkueven, H

Volltext

Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity von Simpson-Yap, Steve, Pirmani, Ashkan, Kalincik, Tomas, De Brouwer, Edward, Geys, Lotte, Parciak, Tina, Helme, Anne, Rijke, Nick, Hillert, Jan A., Moreau, Yves, Edan, Gilles, Sharmin, Sifat, Spelman, Tim, McBurney, Robert, Schmidt, Hollie, Bergmann, Arnfin B., Braune, Stefan, Stahmann, Alexander, Middleton, Rod M., Salter, Amber, Bebo, Bruce, Van der Walt, Anneke, Butzkueven, Helmut, Ozakbas, Serkan, Boz, Cavit, Karabudak, Rana, Alroughani, Raed, Rojas, Juan I., van der Mei, Ingrid A., Sciascia do Olival, Guilherme, Magyari, Melinda, Alonso, Ricardo N., Nicholas, Richard S., Chertcoff, Anibal S., de Torres, Ana Zabalza, Arrambide, Georgina, Nag, Nupur, Descamps, Annabel, Costers, Lars, Dobson, Ruth, Miller, Aleisha, Rodrigues, Paulo, Prčkovska, Vesna, Comi, Giancarlo, Peeters, Liesbet M.

Volltext

Switching to natalizumab or fingolimod in multiple sclerosis: Comparative effectiveness and effect of pre-switch disease activity von Spelman, Tim, Horakova, Dana, Ozakbas, Serkan, Alroughani, Raed, Onofrj, Marco, Kalincik, Tomas, Prat, Alexandre, Terzi, Murat, Grammond, Pierre, Patti, Francesco, Csepany, Tunde, Boz, Cavit, Lechner-Scott, Jeannette, Granella, Franco, Grand'Maison, Francois, van der Walt, Anneke, Zhu, Chao, Butzkueven, Helmut

Volltext

The significance of oligoclonal bands in multiple sclerosis: Relevance of demographic and clinical features, and immunogenetic backgrounds von Idiman, Egemen, Ozakbas, Serkan, Dogan, Yavuz, Kosehasanogullari, Gorkem

Volltext